Sarepta Therapeutics note 1.500% 11/1 shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Sarepta Therapeutics note 1.500% 11/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics note 1.500% 11/1 held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.7k | 1.0k | 1.65 |
| 2024-06-30 | $2.3k | 1.0k | 2.25 |
| 2024-03-31 | $1.8k | 1.0k | 1.75 |
| 2023-12-31 | $1.3k | 1.0k | 1.26 |
| 2023-09-30 | $1.8k | 1.0k | 1.79 |
| 2023-06-30 | $1.7k | 1.0k | 1.69 |
| 2022-12-31 | $1.9k | 1.0k | 1.87 |
| 2022-09-30 | $2.0k | 1.0k | 2.00 |
| 2022-06-30 | $5.5M | 5.5M | 1.00 |
| 2022-03-31 | $5.5M | 5.5M | 1.00 |
| 2021-12-31 | $5.8M | 4.0M | 1.46 |
| 2021-09-30 | $13M | 8.8M | 1.47 |
| 2021-06-30 | $13M | 9.8M | 1.34 |
| 2021-03-31 | $13M | 9.8M | 1.31 |
| 2020-12-31 | $481k | 196k | 2.45 |
| 2020-09-30 | $1.4M | 696k | 2.07 |
| 2020-06-30 | $1.6M | 696k | 2.30 |
| 2020-03-31 | $3.7M | 2.4M | 1.56 |
| 2019-09-30 | $9.5M | 7.2M | 1.32 |
| 2019-06-30 | $12M | 5.4M | 2.21 |
| 2019-03-31 | $15M | 8.3M | 1.80 |
Top funds holding Sarepta Therapeutics note 1.500% 11/1
View all funds holding Sarepta Therapeutics note 1.500% 11/1